Vaccine safety - Open Access .click

Results 231 to 240 of about 183,249 (258)

Some of the next articles are maybe not open access.

Vaccine, 2019
Patrick, Cashman, Sarah, Moberley, David, Durrheim +2 more
openaire +2 more sources

Journal de pharmacie de Belgique, 2002
The high standard of safety that is expected from vaccines can only be obtained if these products undergo in depth evaluation of their side effects before marketing authorization is guaranted, as well as post-marketing surveillance and investigation of reported adverse events. The evaluation of the benefit/risk balance of vaccines is a dynamic process,
openaire +2 more sources

Monitoring vaccine safety using the vaccine safety Datalink: Assessing capacity to integrate data from Immunization Information systems

Vaccine, 2022
Allison Naleway, Michael Jackson, Lina S Sy +2 more
exaly

SAFETY OF PERTUSSIS VACCINE

The Lancet, 1983
T M, Pollock, J, Morris
openaire +2 more sources

Protecting Vaccine Safety: An Improved, Blockchain-Based, Storage-Efficient Scheme

IEEE Transactions on Cybernetics, 2023
Fei Chen, Jianqiang Li, Laizhong Cui
exaly

Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia

Lancet, The, 2020
Amir Tukhvatulin +2 more
exaly

A trial to evaluate the safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine in populations of adults ≥65 years of age with different prior pneumococcal vaccination

Vaccine, 2021
Kathrin U Jansen, Íngrid Scully, Daniel Scott +2 more
exaly

Monitoring the safety of quadrivalent human papillomavirus vaccine: Findings from the Vaccine Safety Datalink

Vaccine, 2011
Allison Naleway, Martin Kulldorff, Eric Weintraub +2 more
exaly